Hear from Xstrahl’s CEO, Adrian Treverton and Technical Service Manager, Wilfried Goetz about increasing throughput in SARRP research with a variety of mouse beds. Radiation research can be done on multiple subjects at once.
CIX3 used in HER2-positive Tumor Research
See what researchers found in the recent study: Enhancement of antitumor immune response by radiation therapy combined with dual immune checkpoint inhibitor in a metastatic model of HER2‑positive murine tumor. See the original publication here.
